Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency.
D002746:Chlorpromazine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005476:Fluphenazine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008297:Male; D010546:Perphenazine / Q000494:pharmacology; D011346:Prochlorperazine / Q000494:pharmacology; D011388:Prolactin / Q000378:metabolism*; D012559:Schizophrenia / Q000188:drug therapy*; D009435:Synaptic Transmission / Q000187:drug effects*; D013888:Thiothixene / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology
D014149:Tranquilizing Agents; D014268:Trifluoperazine; D013888:Thiothixene; D011388:Prolactin; D010546:Perphenazine; D006220:Haloperidol; D005476:Fluphenazine; D002746:Chlorpromazine; D004298:Dopamine; D011346:Prochlorperazine